Archis Pharma LLC
14 drugs in NADAC|14 Generic,0 Brand
Archis Pharma LLC lists 14 NDCs in the CMS NADAC file (14 generic, 0 brand), at an average NADAC of $0.73 per unit, with a week-over-week move of +0.9% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
14
14G / 0B
Avg Price / Unit
$0.7259
$0.09 – $2.88
Avg 7d Change
+0.90%
Across 9 drugs with changes
7d Activity
of 14 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
valsartan market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Angiotensin 2 Receptor Blocker therapeutic class
Review the broader class where Archis Pharma LLC has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Archis Pharma LLC make?
Archis Pharma LLC lists 14 NDCs in the CMS NADAC file — 14 generic and 0 brand products.
What is the average price of Archis Pharma LLC drugs?
The average NADAC across Archis Pharma LLC's portfolio is $0.7259 per unit, ranging from $0.0892 to $2.8764.
What types of drugs does Archis Pharma LLC make?
Archis Pharma LLC makes drugs across 6 FDA pharmacologic classes. The most common by NDC count are Angiotensin 2 Receptor Blocker (4), Atypical Antipsychotic (3), Kinase Inhibitor (2), Tricyclic Antidepressant (2), Antimetabolite Immunosuppressant (2).
Has Archis Pharma LLC had any drug recalls?
No FDA enforcement recalls are matched to Archis Pharma LLC in the openFDA feed.
How has Archis Pharma LLC's pricing changed recently?
Over the past 7 days, 5 Archis Pharma LLC products rose and 4 fell, with a portfolio-wide average change of +0.9%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
IMATINIB MESYLATE 400 MG TAB imatinib mesylate | $2.8764 per EA | — |
DOXEPIN HCL 6 MG TABLET Doxepin | $1.3716 per EA | -5.06% |
DOXEPIN HCL 3 MG TABLET Doxepin | $1.3334 per EA | -2.27% |
PALIPERIDONE ER 9 MG TABLET paliperidone | $1.0557 per EA | +3.64% |
PALIPERIDONE ER 6 MG TABLET paliperidone | $1.0460 per EA | +3.11% |
PALIPERIDONE ER 3 MG TABLET paliperidone | $0.9719 per EA | +6.57% |
IMATINIB MESYLATE 100 MG TAB imatinib mesylate | $0.6114 per EA | — |
MYCOPHENOLIC ACID DR 360 MG TB mycophenilic acid | $0.2216 per EA | -2.17% |
VALSARTAN 320 MG TABLET valsartan | $0.1648 per EA | — |
DICLOFENAC POT 50 MG TABLET diclofenac potassium | $0.1125 per EA | +4.17% |
VALSARTAN 160 MG TABLET valsartan | $0.1123 per EA | — |
MYCOPHENOLIC ACID DR 180 MG TB mycophenilic acid | $0.0996 per EA | +1.09% |
VALSARTAN 40 MG TABLET valsartan | $0.0963 per EA | -1.02% |
VALSARTAN 80 MG TABLET valsartan | $0.0891 per EA | — |